Azenta Life Sciences Overview
- Year Founded
-
1978
- Status
-
Public
- Employees
-
3,300
- Stock Symbol
-
AZTA
- Investments
-
45
- Share Price
-
$45.00
- (As of Thursday Closing)
Azenta Life Sciences General Information
Description
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.
Contact Information
Website
www.azenta.comCorporate Office
- 200 Summit Drive
- Burlington, MA 01803
- United States
Corporate Office
- 200 Summit Drive
- Burlington, MA 01803
- United States
Azenta Life Sciences Stock Performance
As of 05-Dec-2024, Azenta Life Sciences’s stock price is $45.00. Its current market cap is $2.05B with 45.6M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $45.00 | $46.93 | $38.82 - $69.16 | $2.05B | 45.6M | 774K | -$3.09 |
Azenta Life Sciences Financials Summary
As of 30-Sep-2024, Azenta Life Sciences has a trailing 12-month revenue of $656M.
|
In Thousands, USD |
TTM 30-Sep-2024 | FY 2024 30-Sep-2024 | FY 2023 30-Sep-2023 | FY 2022 30-Sep-2022 |
|---|---|---|---|---|
| EV | 1,845,027 | 1,845,027 | 1,908,935 | 1,078,842 |
| Revenue | 656,323 | 656,323 | 665,072 | 555,498 |
| EBITDA | (109,756) | (109,756) | 11,416 | 28,069 |
| Net Income | (164,170) | (164,170) | (14,257) | 2,132,859 |
| Total Assets | 2,100,041 | 2,100,041 | 2,885,720 | 3,716,122 |
| Total Debt | 58,792 | 58,792 | 60,436 | 49,227 |
Azenta Life Sciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Azenta Life Sciences Comparisons
Industry
Financing
Details
Azenta Life Sciences Competitors (5)
One of Azenta Life Sciences’s 5 competitors is GenScript, a Formerly VC-backed company based in Piscataway, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| GenScript | Formerly VC-backed | Piscataway, NJ | ||||
| Hamilton Company | Corporation | Reno, NV | ||||
| BGI Genomics | Formerly VC-backed | Shenzhen, China | ||||
| DSM-Firmenich | Corporation | Kaiseraugst, Switzerland | ||||
| Eurofins Scientific | Corporation | Luxembourg, Luxembourg |
Azenta Life Sciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Azenta Life Sciences Patents
Azenta Life Sciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240399377-A1 | Large-scale biological sample storage | Pending | 18-May-2023 | ||
| EP-4443236-A1 | Stocker compartment | Pending | 05-Apr-2023 | ||
| EP-4258330-A1 | Stocker pod, method and stocker for storing a semiconductor fabrication article | Pending | 08-Apr-2022 | ||
| EP-4430453-A1 | Stocker system | Pending | 08-Nov-2021 | ||
| JP-2024542396-A | Stocker system | Pending | 08-Nov-2021 | G03F7/70741 |
Azenta Life Sciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Azenta Life Sciences Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Azenta Life Sciences Investments & Acquisitions (45)
Azenta Life Sciences’s most recent deal was a Merger/Acquisition with Ziath for . The deal was made on 02-Feb-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Ziath | 02-Feb-2023 | Merger/Acquisition | Other Devices and Supplies | ||
| B Medical Systems | 03-Oct-2022 | Merger/Acquisition | Other Devices and Supplies | ||
| Barkey | 10-Jun-2022 | Merger/Acquisition | Other Devices and Supplies | ||
| Precise Automation | 29-Apr-2021 | Merger/Acquisition | Other Hardware | ||
| Abeyance Cryo | 02-Apr-2021 | Merger/Acquisition | Buildings and Property |
Azenta Life Sciences Subsidiaries (5)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Ziath | Other Devices and Supplies | Cambridge, United Kingdom | 2005 |
| Genewiz | Biotechnology | South Plainfield, NJ | |
| Barkey | Other Devices and Supplies | Leopoldshoehe, Germany | |
| B Medical Systems | Other Devices and Supplies | Hosingen, Luxembourg | |
| Abeyance Cryo | Buildings and Property | Springfield, MO |
Azenta Life Sciences ESG
Risk Overview
Risk Rating
Updated May, 31, 2024
15.89 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,100
Rank
Percentile
Pharmaceuticals
Industry
of 851
Rank
Percentile
Laboratory Equipment and Services
Subindustry
of 60
Rank
Percentile
Azenta Life Sciences Exits (3)
Azenta Life Sciences’s most recent exit was on 24-Mar-2014 from BioCision. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| BioCision | 24-Mar-2014 | Completed |
|
||
| Progressive Technologies | 12-Jul-2001 | Completed |
|
||
| Ulvac Cryogenics | 01-Jan-1981 | Joint Venture | Completed |
|
Azenta Life Sciences FAQs
-
When was Azenta Life Sciences founded?
Azenta Life Sciences was founded in 1978.
-
Where is Azenta Life Sciences headquartered?
Azenta Life Sciences is headquartered in Burlington, MA.
-
What is the size of Azenta Life Sciences?
Azenta Life Sciences has 3,300 total employees.
-
What industry is Azenta Life Sciences in?
Azenta Life Sciences’s primary industry is Biotechnology.
-
Is Azenta Life Sciences a private or public company?
Azenta Life Sciences is a Public company.
-
What is Azenta Life Sciences’s stock symbol?
The ticker symbol for Azenta Life Sciences is AZTA.
-
What is the current stock price of Azenta Life Sciences?
As of 05-Dec-2024 the stock price of Azenta Life Sciences is $45.00.
-
What is the current market cap of Azenta Life Sciences?
The current market capitalization of Azenta Life Sciences is $2.05B.
-
What is Azenta Life Sciences’s current revenue?
The trailing twelve month revenue for Azenta Life Sciences is $656M.
-
Who are Azenta Life Sciences’s competitors?
GenScript, Hamilton Company, BGI Genomics, DSM-Firmenich, and Eurofins Scientific are competitors of Azenta Life Sciences.
-
What is Azenta Life Sciences’s annual earnings per share (EPS)?
Azenta Life Sciences’s EPS for 12 months was -$3.09.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
